ICON Public Limited Company
ICLR
Hisse Senetlerindeki Sıralama
#1655
ICON Public Limited Company, a clinical research organization, provides... ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including all phases of development, peri and post approval, data solutions, and site and patient access services; clinical trial management, consulting, and contract staffing services; and commercial services comprising clinical development strategy, planning and trial design, full study execution, and post-market commercialization. In addition, the company offers laboratory services, including bionanalytical, biomarker, vaccine, good manufacturing practice, and central laboratory services, as well as full-service and functional service partnerships to customers. Further, the company provides adaptive trials, cardiac safety solutions, clinical and scientific operations, consulting and advisory, commercial positioning, decentralized and hybrid clinical trials, early clinical, laboratories, language services, medical imaging, real world intelligence, site and patient, and strategic solutions. It serves pharmaceutical, biotechnology, and medical device industries, as well as government and public health organizations. The company has a strategic alliance with Advarra, Inc. for the development of a connected, research-ready clinical trial site network model. ICON Public Limited Company was incorporated in 1989 and is headquartered in Dublin, Ireland.
Hisse Fiyatı
$168.25
Son senkronizasyon: 2026-10-16
Piyasa Değeri
$12.98B
Değişim (1 gün)
-3.93%
Değişim (1 yıl)
-9.08%
Ülke
IE
Ticaret ICON Public Limited Company (ICLR)
Kategori
Healthcare
ICON Public Limited Company (ICLR) için Faaliyet Marjı
October 2026 itibarıyla Faaliyet Marjı TTM: 10.15%
ICON Public Limited Company şirketinin en son finansal raporlarına ve hisse fiyatına göre, mevcut faaliyet marjı (TTM) 10.15%'dir. 2023 yılı sonunda şirketin faaliyet marjı 11.78% idi.
ICON Public Limited Company için 2001 ile 2026 arasındaki Faaliyet Marjı geçmişi
Her yıl sonunda Faaliyet Marjı
| Yıl | Faaliyet Marjı | Değiştir |
|---|---|---|
| 2026 (TTM) | 10.15% | -23.45% |
| 2024 | 13.26% | 12.56% |
| 2023 | 11.78% | 14.70% |
| 2022 | 10.27% | 48.63% |
| 2021 | 6.91% | -50.64% |
| 2020 | 14.00% | -9.39% |
| 2019 | 15.45% | 7.44% |
| 2018 | 14.38% | -25.26% |
| 2017 | 19.24% | 2.89% |
| 2016 | 18.70% | 4.59% |
| 2015 | 17.88% | 32.84% |
| 2014 | 13.46% | 48.40% |
| 2013 | 9.07% | 39.54% |
| 2012 | 6.50% | 56.63% |
| 2011 | 4.15% | -59.43% |
| 2010 | 10.23% | -15.52% |
| 2009 | 12.11% | 5.30% |
| 2008 | 11.50% | 4.74% |
| 2007 | 10.98% | 4.57% |
| 2006 | 10.50% | 83.57% |
| 2005 | 5.72% | -50.60% |
| 2004 | 11.58% | 4.89% |
| 2003 | 11.04% | -5.07% |
| 2002 | 11.63% | 22.04% |
| 2001 | 9.53% | 0.00% |
Benzer şirketler veya rakipler için Faaliyet Marjı
| Şirket | Faaliyet Marjı | Faaliyet Marjı Farkı | Ülke |
|---|---|---|---|
| 17.97% | -98.23% |
US
|
|
| 20.42% | -97.99% |
US
|
|
| -10.70% | -101.05% |
US
|
|
| 0.00% | - |
CN
|
|
| 22.23% | -97.81% |
US
|
Bir şirketin Faaliyet Marjı'ı nedir?
Faaliyet Marjı, bir şirketin kârlılığını değerlendirmek için temel bir göstergedir. Daha yüksek Faaliyet Marjı değerleri genellikle daha iyidir çünkü bir şirketin ürün veya hizmetlerini üretim maliyetlerinden çok daha yüksek bir fiyata satabildiğini gösterir. Faaliyet Marjı, şirketin kârının gelirine bölünmesiyle hesaplanır.